Christopher Sampson

I completed my PhD in molecular biology, specialising in the Rho-family small GTPases and subsequent Dock180 GEFs, in the control of actin. Using these skills I moved to a post-doc position to support the characterisation of a novel family of genes that encode for small proteins (smORFs). And since then have moved to industry where I initially worked in process research across Biopharms and cell & gene therapy (CGT) but have since focussed on QC oversight of GMP operations in CGT.